AIInc42about 3 hours ago
Graph AI In Talks For $14 Mn Series A
2 min read
Pharmaceutical AI startup Graph AI is in talks to raise $14 Mn in a Series A round led by Insight Partners, with participation from existing investor Bessemer Venture Partners. The company offers an AI-native platform called Graph Safety for automating adverse drug event monitoring and regulatory compliance.
Level
Hype check
Tap to vote and see what everyone thinks.
